Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 1591-1595, March 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by Anderson, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by Anderson, M. W.

Mutational Activation of the Cellular Harvey ras Oncogene in Rat Esophageal Papillomas Induced by Methylbenzylnitrosamine1

Yian Wang, Ming You, Steven H. Reynolds, Gary D. Stoner and Marshall W. Anderson

Department of Pathology, Medical College of Ohio, Toledo, Ohio 43699 [Y. W., M. Y., G. D. S.], and Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [Y. W., M. Y., S. H. R., M. W. A.]

Epidemiological studies have demonstrated a strong association between human esophageal cancer and exposure to N-nitroso carcinogens. Esophageal tumors can be induced in experimental animals, especially in rats, by many N-nitroso carcinogens. In the present study, rat esophageal tumors induced by methylbenzylnitrosamine (MBNA) and MBNA-transformed esophageal cell lines were analyzed for activated protooncogenes. DNAs from four Fisher 344 rat esophageal papillomas were examined for their ability to induce morphological transformation of NIH 3T3 cells. One of four esophageal tumors was positive in this assay. Southern blot analysis of this NIH 3T3 transformant revealed that the transforming gene was an activated Ha-ras gene. The activating mutation in the Ha-ras gene was identified by amplifying and then sequencing the first exon of this gene. A GC -> AT transition at the second base in codon 12 of the Ha-ras gene was detected. The tumor DNAs from the transfection-negative samples were also amplified, and sequencing analysis of the first exon revealed a GC -> AT transition in codon 12. In addition, 14 formalin-fixed and paraffin-embedded rat esophageal papillomas were shown to contain the same mutation in one of the alleles of the Ha-ras gene. In contrast, no point mutation was found in codons 12, 13, and 61 of the Ha-, Ki-, or N-ras genes in MBNA-transformed rat esophageal cell lines. The GC -> AT transition detected in the esophageal tumors by DNA sequencing was confirmed by slot blot oligonucleotide hybridization of the polymerase chain reaction-amplified DNAs. The fact that mutated Ha-ras genes were detected in the esophageal papillomas suggests that activation of this gene occurred early in the process of neoplastic progression. The point mutation detected in the Ha-ras gene appears to result from a direct genotoxic effect of MBNA involving formation of the O6-methylguanine adduct. Taken together, these studies suggest that the activation of the Ha-ras gene plays an important role in the induction of esophageal neoplasia in the Fisher 344 rat by MBNA.

1 This research was supported, in part, by National Cancer Institute Grant CA 28950.

Received 7/26/89. Revised 11/17/89. Accepted 11/28/89.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
G. D. Stoner, L.-S. Wang, and B. C. Casto
Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries
Carcinogenesis, September 1, 2008; 29(9): 1665 - 1674.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Chen, H. Hwang, M. E. Rose, R. G. Nines, and G. D. Stoner
Chemopreventive Properties of Black Raspberries in N-Nitrosomethylbenzylamine-Induced Rat Esophageal Tumorigenesis: Down-regulation of Cyclooxygenase-2, Inducible Nitric Oxide Synthase, and c-Jun.
Cancer Res., March 1, 2006; 66(5): 2853 - 2859.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. W. Liston, R. Nines, P. S. Carlton, A. Gupta, R. Aziz, W. Frankel, and G. D. Stoner
Perillyl Alcohol as a Chemopreventive Agent in N-Nitrosomethylbenzylamine-induced Rat Esophageal Tumorigenesis
Cancer Res., May 15, 2003; 63(10): 2399 - 2403.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Y. Y. Fong, H. Ishii, V. T. Nguyen, A. Vecchione, J. L. Farber, C. M. Croce, and K. Huebner
p53 Deficiency Accelerates Induction and Progression of Esophageal and Forestomach Tumors in Zinc-deficient Mice
Cancer Res., January 1, 2003; 63(1): 186 - 195.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. S. Carlton, R. Gopalakrishnan, A. Gupta, B. W. Liston, S. Habib, M. A. Morse, and G. D. Stoner
Piroxicam Is an Ineffective Inhibitor of N-Nitrosomethylbenzylamine-induced Tumorigenesis in the Rat Esophagus
Cancer Res., August 1, 2002; 62(15): 4376 - 4382.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. D. Stoner and A. Gupta
Etiology and chemoprevention of esophageal squamous cell carcinoma
Carcinogenesis, November 1, 2001; 22(11): 1737 - 1746.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Qin, H. Zhou, L. Liu, and S. L. Gerson
Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis
Carcinogenesis, September 1, 1999; 20(9): 1667 - 1673.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. E. Graham, J. R. Pfeiffer, R. J. Lee, D. F. Kusewitt, A. M. Martinez, T. Foutz, B. S. Wilson, and J. M. Oliver
MEK and ERK Activation in Ras-Disabled RBL-2H3 Mast Cells and Novel Roles for Geranylgeranylated and Farnesylated Proteins in Fc{epsilon}RI-Mediated Signaling
J. Immunol., December 15, 1998; 161(12): 6733 - 6744.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.